• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在用于测量低血糖意识受损的工具中区分低血糖意识状态和低血糖体验。

Differentiating Hypoglycemia Awareness Status from Hypoglycemia Experience in Tools for Measuring Impaired Awareness of Hypoglycemia.

机构信息

Centre for Psychology at University of Porto, Faculty of Psychology and Educational Sciences, University of Porto, Porto, Portugal.

Department of Diabetes, School of Life Course Sciences, King's College London, London, United Kingdom.

出版信息

Diabetes Technol Ther. 2020 Jul;22(7):541-545. doi: 10.1089/dia.2020.0034.

DOI:10.1089/dia.2020.0034
PMID:32175769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7336879/
Abstract

Developing technologies in real-time continuous glucose monitoring (CGM) are successfully reducing severe hypoglycemia (SH) in trials and clinical practice. Their impact on impaired awareness of hypoglycemia, a major risk factor for SH, is uncertain. The present study examined two scales for assessing hypoglycemia awareness status, the Gold score and the eight-item Minimally Modified Clarke Hypoglycemia Survey (MMCHS), commonly used in trials of CGM, in Portuguese-speaking adults with type 1 diabetes and conducted an exploratory factor analysis on MMCHS. A bifactorial structure in MMCHS was revealed, with a clear distinction between items that measure SH experience and those that measure hypoglycemia awareness status. The latter is associated with the same risk for SH as the Gold score. We conclude that improvement in awareness scores by the MMCHS may reflect only a reduction in SH with no restoration of endogenous awareness, making the current literature consistent in evidence that CGM does not improve endogenous awareness and nonsensor supported protection from SH. This has implications for risk of SH when CGM is not being worn.

摘要

实时连续血糖监测 (CGM) 技术的发展在试验和临床实践中成功降低了严重低血糖 (SH) 的发生。但其对低血糖意识受损的影响,这是 SH 的一个主要危险因素,尚不确定。本研究使用两种评估低血糖意识状态的量表,即 Gold 评分和常用于 CGM 试验的八条目最小修正 Clarke 低血糖调查 (MMCHS),对葡语母语的 1 型糖尿病成年人进行了评估,并对 MMCHS 进行了探索性因子分析。MMCHS 呈现出双因素结构,其中明确区分了衡量 SH 体验的项目和衡量低血糖意识状态的项目。后者与 Gold 评分一样,与 SH 的风险相关。我们得出结论,MMCHS 的意识评分的提高可能仅反映了 SH 的减少,而没有恢复内源性意识,这与 CGM 不能改善内源性意识和无传感器支持的 SH 保护的现有文献证据一致。这意味着在不佩戴 CGM 时,SH 的风险会增加。

相似文献

1
Differentiating Hypoglycemia Awareness Status from Hypoglycemia Experience in Tools for Measuring Impaired Awareness of Hypoglycemia.在用于测量低血糖意识受损的工具中区分低血糖意识状态和低血糖体验。
Diabetes Technol Ther. 2020 Jul;22(7):541-545. doi: 10.1089/dia.2020.0034.
2
Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study.使用智能手机应用程序降低1型糖尿病患者低血糖发生率:一项试点研究。
J Diabetes Sci Technol. 2018 Nov;12(6):1192-1199. doi: 10.1177/1932296817749859. Epub 2018 Jan 1.
3
IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.尽管在 1 型糖尿病中使用了连续血糖监测系统,但低血糖意识受损仍然是严重低血糖的一个风险因素。
Endocr Pract. 2019 Jun;25(6):517-525. doi: 10.4158/EP-2018-0527. Epub 2019 Mar 13.
4
Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems.使用连续血糖监测系统的 1 型糖尿病患者的低血糖时间与低血糖意识状态之间的关系。
Diabetes Technol Ther. 2020 Nov;22(11):787-793. doi: 10.1089/dia.2020.0016. Epub 2020 Oct 13.
5
Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions.减轻先进糖尿病技术使用者的严重低血糖:以意识受损的低血糖和无益的低血糖信念为干预目标。
Diabetes Technol Ther. 2024 Oct;26(10):739-747. doi: 10.1089/dia.2024.0039. Epub 2024 Apr 29.
6
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.1 型糖尿病且低血糖感知受损患者的连续血糖监测(IN CONTROL):一项随机、开放标签、交叉试验。
Lancet Diabetes Endocrinol. 2016 Nov;4(11):893-902. doi: 10.1016/S2213-8587(16)30193-0. Epub 2016 Sep 15.
7
Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.胰岛素类似物对 1 型糖尿病易发生严重低血糖患者非严重低血糖发生频率的影响:连续血糖监测检测到的发生率远高于自我血糖监测——HypoAna 试验。
Diabetes Technol Ther. 2018 Mar;20(3):247-256. doi: 10.1089/dia.2017.0372. Epub 2018 Mar 12.
8
Interventions That Restore Awareness of Hypoglycemia in Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis.干预措施恢复 1 型糖尿病成人低血糖意识:系统评价和荟萃分析。
Diabetes Care. 2015 Aug;38(8):1592-609. doi: 10.2337/dc15-0102.
9
Real life evidence that impaired awareness of hypoglycemia persists for years in patients with type 1 diabetes.现实生活中的证据表明,1 型糖尿病患者的低血糖意识障碍会持续多年。
J Diabetes Complications. 2018 Dec;32(12):1097-1099. doi: 10.1016/j.jdiacomp.2018.08.015. Epub 2018 Sep 1.
10
Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.高风险 1 型糖尿病成人应用连续血糖监测与间歇性扫描连续血糖监测比较的血糖变异性和低血糖事件。
J Diabetes Sci Technol. 2020 May;14(3):567-574. doi: 10.1177/1932296819867688. Epub 2019 Aug 2.

引用本文的文献

1
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes.技术对1型糖尿病患者低血糖意识受损的影响。
Ther Adv Endocrinol Metab. 2025 Jun 12;16:20420188251346260. doi: 10.1177/20420188251346260. eCollection 2025.
2
The challenge of assessing impaired awareness of hypoglycaemia in diabetes in the era of continuous glucose monitoring: A narrative review of evidence and translation into clinical practice.在持续血糖监测时代评估糖尿病患者低血糖意识受损的挑战:证据的叙述性综述及转化为临床实践
Diabetes Obes Metab. 2025 May;27(5):2363-2376. doi: 10.1111/dom.16284. Epub 2025 Feb 25.
3
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes.在近期使用先进闭环系统的患者中,比较传统面对面就诊与远程医疗结合面对面随访的混合方式的生活质量:一项1型糖尿病患者的随机对照临床试验。
Ther Adv Endocrinol Metab. 2024 Oct 25;15:20420188241288789. doi: 10.1177/20420188241288789. eCollection 2024.
4
Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.通过低血糖意识问卷(HypoA-Q)对低血糖意识受损及相关风险进行特征分析:1型糖尿病交流队列研究结果
Diabetologia. 2025 Feb;68(2):433-443. doi: 10.1007/s00125-024-06310-5. Epub 2024 Oct 30.
5
Use of machine learning to identify characteristics associated with severe hypoglycemia in older adults with type 1 diabetes: a post-hoc analysis of a case-control study.使用机器学习识别与 1 型糖尿病老年患者严重低血糖相关的特征:一项病例对照研究的事后分析。
BMJ Open Diabetes Res Care. 2024 Feb 27;12(1):e003748. doi: 10.1136/bmjdrc-2023-003748.
6
Current and future therapies to treat impaired awareness of hypoglycemia.治疗低血糖意识障碍的当前及未来疗法。
Front Pharmacol. 2023 Oct 24;14:1271814. doi: 10.3389/fphar.2023.1271814. eCollection 2023.
7
Validating and Establishing a Diagnostic Threshold for the Hypoglycemia Awareness Questionnaire Impaired Awareness Subscale.验证和确定低血糖意识问卷受损意识分量表的诊断阈值。
Endocr Pract. 2023 Oct;29(10):762-769. doi: 10.1016/j.eprac.2023.08.004. Epub 2023 Aug 21.
8
Challenges and Perspectives for Future Considerations in the Bioengineering of a Bioartificial Pancreas.生物人工胰腺的生物工程学未来考虑的挑战和展望。
Ann Biomed Eng. 2024 Jul;52(7):1795-1803. doi: 10.1007/s10439-023-03180-7. Epub 2023 Mar 13.
9
Automated Insulin Delivery for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes with Hypoglycemia Unawareness.用于避免低血糖和纠正低血糖感知障碍的 1 型糖尿病患者的血糖自动化输注。
Diabetes Technol Ther. 2023 May;25(5):302-314. doi: 10.1089/dia.2022.0506. Epub 2023 Feb 24.
10
Epidemiological, Social and Economic Burden of Severe Hypoglycaemia in Patients with Diabetes Mellitus in Portugal: A Structured Literature Review.葡萄牙糖尿病患者严重低血糖的流行病学、社会和经济负担:一项结构化文献综述
Diabetes Ther. 2023 Feb;14(2):265-291. doi: 10.1007/s13300-022-01358-1. Epub 2023 Jan 21.

本文引用的文献

1
Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study).家庭成员:糖尿病照护团队中被遗忘的参与者(TALK-HYPO研究)
Diabetes Ther. 2019 Dec;10(6):2305-2311. doi: 10.1007/s13300-019-00687-y. Epub 2019 Sep 9.
2
IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.尽管在 1 型糖尿病中使用了连续血糖监测系统,但低血糖意识受损仍然是严重低血糖的一个风险因素。
Endocr Pract. 2019 Jun;25(6):517-525. doi: 10.4158/EP-2018-0527. Epub 2019 Mar 13.
3
Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.实时连续血糖监测在 1 型糖尿病成人中应用:多日胰岛素注射治疗伴低血糖感知受损或严重低血糖的患者(HypoDE):一项多中心、随机对照试验。
Lancet. 2018 Apr 7;391(10128):1367-1377. doi: 10.1016/S0140-6736(18)30297-6. Epub 2018 Feb 16.
4
A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.一项关于连续血糖监测和瞬感血糖监测在 1 型糖尿病合并感知性低血糖人群中应用的随机对照初步研究。
Diabet Med. 2018 Apr;35(4):483-490. doi: 10.1111/dme.13561. Epub 2017 Dec 29.
5
Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes.长期 1 型糖尿病患者中避免低血糖和葡萄糖反向调节的连续血糖监测。
J Clin Endocrinol Metab. 2018 Jan 1;103(1):105-114. doi: 10.1210/jc.2017-01516.
6
International Consensus on Use of Continuous Glucose Monitoring.连续血糖监测应用的国际共识
Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
7
Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.一项针对27585名1型糖尿病患者和接受胰岛素治疗的2型糖尿病患者的全球24国研究中,低血糖对患者报告结局的影响。
Diabetes Res Clin Pract. 2017 Aug;130:121-129. doi: 10.1016/j.diabres.2017.05.004. Epub 2017 May 12.
8
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes.血糖浓度低于3.0毫摩尔/升(54毫克/分升)的情况应在临床试验中报告:美国糖尿病协会和欧洲糖尿病研究协会的联合立场声明。
Diabetologia. 2017 Jan;60(1):3-6. doi: 10.1007/s00125-016-4146-6.
9
Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.1 型糖尿病且低血糖感知受损患者的连续血糖监测(IN CONTROL):一项随机、开放标签、交叉试验。
Lancet Diabetes Endocrinol. 2016 Nov;4(11):893-902. doi: 10.1016/S2213-8587(16)30193-0. Epub 2016 Sep 15.
10
Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics.澳大利亚 1 型糖尿病专科三级诊所就诊成人患者重度低血糖及其与心理健康的关系。
Diabetes Res Clin Pract. 2014 Mar;103(3):430-6. doi: 10.1016/j.diabres.2013.12.005. Epub 2014 Jan 8.